Advertisement

Utah Medical Products, Inc. UTMD

Set alert

Price alert · UTMD

All alert types
70.55 USD +2.47 +3.64%

At close · Nov 2

70.55 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
70.55 × 2
Ask
71.00 × 2
68.71 Day range 71.05
53.66 52-week range 76.89
YTD
+26.07%
1 year
+21.43%
Open
68.83
Prev close
68.08
Mkt cap
200.87M
Vol
38.99K
Avg vol
35.54K
EPS
3.34
P/E
21.12
Div yield
2.00%
More statistics
Low
68.71
High
71.05
Forward P/E
0.00
Beta
0.08
Short ratio
2.77
Inst. own
73.66%
Dividend
1.22
Ex-div date
Dec 15, 2024
50-d avg
64.91
200-d avg
67.23
1y target
0.00

6M chart

Chart tools
Interval

Events in this range
  • Jun 17, 2026Dividend: 0.31
  • Sep 17, 2026Dividend: 0.31
Signals (28)
NameDateAgo
SMA: BearishOct 28, 20265 days ago
RSI: OversoldOct 28, 20265 days ago
SMA: BearishOct 27, 20266 days ago
MACD: Sell SignalOct 2, 20261 month ago
MACD: Buy SignalSep 15, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 8, 20261 month ago
MACD: Sell SignalAug 20, 20262 months ago
MACD: Buy SignalAug 19, 20262 months ago
MACD: Sell SignalAug 17, 20262 months ago
MACD: Buy SignalJul 29, 20263 months ago
SMA: BullishJul 27, 20263 months ago
SMA: BullishJul 24, 20263 months ago
SMA: BearishJul 23, 20263 months ago
SMA: BearishJul 23, 20263 months ago
MACD: Sell SignalJul 8, 20263 months ago
MACD: Buy SignalJun 26, 20264 months ago
SMA: BullishJun 24, 20264 months ago
SMA: BullishJun 24, 20264 months ago
SMA: BearishJun 23, 20264 months ago
SMA: BearishJun 22, 20264 months ago
SMA: BullishJun 18, 20264 months ago
SMA: BearishJun 17, 20264 months ago
MACD: Sell SignalJun 17, 20264 months ago
MACD: Buy SignalMay 26, 20265 months ago
SMA: BullishMay 18, 20265 months ago
SMA: BearishMay 15, 20265 months ago
SMA: BearishMay 4, 20266 months ago

Key statistics

Market cap
207.33M
Enterprise value
121.79M
Trailing P/E
14.28
Forward P/E
0.00
PEG ratio
0.00
Price / sales
4.70
Price / book
1.69
EPS (TTM)
4.28
Beta
0.08
Dividend yield
2.00%
Payout ratio
28.04%
Profit margin
34.62%
Revenue (TTM)
44.08M
Revenue growth
-20.00%
Free cash flow
0
Total cash
88.45M
Total debt
299.00K
Return on equity
12.31%
Shares outstanding
3.39M
Short % of float
2.33%
50-day average
64.91
200-day average
67.23

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
UTMD Revenue — quarterly 8.53M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
UTMD Net income — quarterly 2.69M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
UTMD EPS — quarterly 0.84
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

UTMD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Oct 29, 2024Sep 1, 20240.001.02——
Jul 25, 2024Jun 1, 20240.000.98——
Apr 25, 2024Mar 1, 20240.001.09——
Jan 30, 2024Dec 1, 20230.001.18——
Oct 26, 2023Sep 1, 20230.001.08——
Jul 25, 2023Jun 1, 20230.001.15——

About Utah Medical Products, Inc.

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
utahmed.com

News

Your note

Sign in to keep a note on UTMD — it syncs with the Stock Master app.

Insider holders

UTMD insider holders
InsiderRelationLatest transactionDateShares held
KOOPMAN BRIAN L.OfficerStock GiftJul 17, 2024882
PAYNE BARBARA ADirectorStock GiftFeb 7, 20234,838
RICHINS PAUL ODirectorStock GiftMay 16, 20240

Institution ownership

UTMD institution ownership
Holder% heldSharesValueReported
FMR, LLC7.93%268,82316.43MSep 29, 2024
Renaissance Technologies, LLC6.80%230,61414.10MSep 29, 2024
Vanguard Group Inc5.34%181,16911.07MSep 29, 2024
Blackrock Inc.5.31%180,09511.01MSep 29, 2024
Dimensional Fund Advisors LP5.17%175,50410.73MSep 29, 2024
Brandes Investment Partners L.P.4.08%138,3658.46MSep 29, 2024

Fund ownership

UTMD fund ownership
Holder% heldSharesValueReported
Fidelity Low-Priced Stock Fund3.56%120,6377.37MAug 30, 2024
Vanguard Total Stock Market Index Fund3.19%108,0966.61MSep 29, 2024
Fidelity Small Cap Discovery Fund1.70%57,5003.51MAug 30, 2024
iShares Russell 2000 ETF1.68%56,9653.48MOct 30, 2024
JP Morgan Small Cap Blend Fund1.65%56,1253.43MSep 29, 2024
Vanguard Extended Market Index Fund1.44%48,7962.98MSep 29, 2024
Advertisement